Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > Fraud in nucleic acid institutions is frequent! The National Health Commission responded: deal with it seriously

Fraud in nucleic acid institutions is frequent! The National Health Commission responded: deal with it seriously

yaozh.com 2022-12-01

01

The nucleic acid territory behind "Zhang Nucleon"

He has been punished more than 10 times

 

Behind the whole network search for "Zhang Shanshan", nuclear genes surfaced.

 

Behind the more than 30 medical testing companies or gene-related companies where Zhang Shanshan works is Zhang Nuzi, the founder of Shenzhen Nuclear Gene Technology Co., Ltd. (hereinafter referred to as "Nuclear Gene").

 

Zhang Nuzi was revealed to start in the home improvement industry, luxury cars, villa parties. On November 28, Zhang Atom, Zhang's younger brother, told the Science and Technology Innovation Board Daily that his family was an ordinary family, "We are all very low-key, this information is clear, we are not obliged to issue any clarification." “

 

According to the Qichacha APP, there are 80 member companies of the group to which Nuclear Gene belongs, a total of 7 enterprises are simply deregistered, a total of nearly 30 court announcements are related, most of the reasons are service contract disputes, etc., a total of 15 administrative punishment information is related, and the administrative punishment time is mostly concentrated in 2022.

 

In detail, there have been more than 10 violations of the law by medical testing related enterprises affiliated with nuclear gene in China, and the reasons for the violations include: not placing infectious medical waste in special packaging, lying about test results, forging medical documents, and the reviewer of nucleic acid test reports is different from the actual auditor.

 

Under the umbrella of Nuclear Gene, it not only includes nuclear Huaxi in various places, but also Huaxi Medical Laboratory, Ruiyin Medical Laboratory, etc.

 

02

Three years of the pandemic

Newly registered nucleic acid enterprises have surged

 

According to enterprise investigation data, there are 2,660 medical testing related enterprises in China, and 1,967 exist.

 

In 2021, 314 new medical testing related enterprises were added, a year-on-year increase of 23.6%; In the first half of 2022, 237 new registrations were registered, a year-on-year increase of 51.9%.

 

In terms of regional distribution, whether in 2021 or the first half of 2022, the top three places with medical testing related enterprises are: Guangdong, Beijing and Jiangsu.

 

According to the data of "Medical Testing Related Enterprise Registration & Growth Trend in the Past Decade" statistics, the number of medical testing related enterprise registrations has shown an upward trend year by year in the past ten years, of which the number of registrations in 2015, 2016 and 2017 increased the most, increasing by 155.9%, 81.6% and 58.9% year-on-year to 87, 158 and 251 respectively. In 2021, 314 new companies were added, a year-on-year increase of 23.6%, and from January to mid-May 2022, 145 new medical testing related enterprises were added in China.

 

According to enterprise investigation data, from the perspective of urban distribution, there are 195 medical testing related enterprises in Beijing, ranking first, and 162 in Shenzhen, second only to Beijing; The number of existing related enterprises in Shanghai, Hangzhou and Wuhan is more than 70, with 99, 90 and 86 respectively. After that, it was Chengdu, Hefei and other cities.

 

03

Fraud by nucleic acid institutions is frequent

Official response: Some have been held criminally responsible

 

For a time, the registration of medical nucleic acid enterprises surged, and the regulatory authorities ushered in regulatory problems, and various places also issued notices on this many times.

 

This afternoon (November 29), at a press conference held by the joint prevention and control mechanism of the State Council, Guo Yanhong, director of the Department of Medical Emergency Response of the National Health Commission, said in response to reporters' questions:

 

"For nucleic acid testing, we have always been strict about the access and quality control of testing qualifications, constantly optimizing technical specifications, and focusing on strengthening the supervision of testing institutions, including third-party testing institutions. Since the beginning of this year, the health administrative departments of Beijing, Hefei, Anhui, Shijiazhuang, Hebei, Xuchang, Inner Mongolia and other places have found some violations of laws and regulations in the supervision of testing institutions, and have all imposed serious penalties. Some offending institutions and individuals have also been held criminally responsible. “

 

"In the next step, we will continue to strengthen supervision and resolutely deal with serious violations of the law by issuing false test reports."

 

It is worth mentioning that "some illegal institutions and individuals are not ruled out from pursuing criminal responsibility."

 

On November 11, the Kunming Municipal Health Commission issued a notice that the Kunming Huanji Medical Laboratory had been placed on file for investigation due to chaotic management, lax quality control, and dereliction of duty.

 

Since the beginning of this year, a number of nucleic acid testing institutions have been investigated for suspected violations.

 

In May ~ June this year, Beijing Pushi Medical Laboratory Co., Ltd., Beijing Jinquan Medical Laboratory Co., Ltd., and Beijing Zhongtong Lambo Medical Laboratory Co., Ltd. were all placed on file for investigation by the public security organs on suspicion of obstructing the prevention and control of infectious diseases.

 

On September 14, according to the website of the Shanghai Municipal Bureau for Market Regulation, Kuoran Medical Laboratory Co., Ltd. was confiscated more than 350,000 yuan of illegal income and fined 33,000 yuan by the Shanghai Jiading District Market Supervision Administration.

 

On September 24, the Shijiazhuang Municipal Public Security Bureau in Hebei Province issued a notice that the Shijiazhuang Hehe Medical Laboratory was suspected of illegal crimes, and the Shijiazhuang police had opened a case for investigation.

 

In the next step, the strict investigation and supervision of nucleic acid testing institutions in various places will continue.

 

04

Some nucleic acid enterprises began to write off

Nucleic acid companies have no future?

 

Recently, many places have issued notices to reduce nucleic acid for all employees; In addition, Guangzhou, Beijing and other places notified that long-term home-based elderly, daily online class students, home workers and other personnel without social activities, if there is no need to go out, can not participate in the nucleic acid screening of all employees to reduce the risk of infection in crowd gathering.

 

Is nucleic acid testing still a "good business"? Industry insiders generally believe that nucleic acid companies have no future.

 

At the same time as the new registration of nucleic acid enterprises, some enterprises began to deregister.

 

According to enterprise investigation data, there are 1,967 existing medical testing-related enterprises in China, and a total of 271 have been cancelled and revoked.

 

In terms of years, the peak of enterprise cancellation and revocation is concentrated in the past three years, with 55, 53 and 57 medical testing-related enterprises canceled and revoked in 2019, 2020 and 2021 respectively, and as of November 29, 52 related enterprises were cancelled and revoked in 2022.

 

The story of "Zhang Shanshan", Zhang Nucleon and Nuclear Gene may not be over yet, or it may be the beginning of a strict investigation of medical testing companies.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.